top of page
New drug Express
Drug r&d newsletter | pharmaceutical insight
Search
946405272
Aug 22, 20232 min read
The Impact of Ziyin Jianghuo Decoction on Salivary Gland Health
Introduction Salivary gland disorders can significantly impact a person's quality of life. Reduced salivary secretion can lead to...
946405272
Aug 22, 20233 min read
Ziyinxiehuo Granules: A Comprehensive Guide to Herbal Medicine
Introduction In the world of herbal medicine, Ziyinxiehuo Granules have gained significant attention for their potential health benefits....
946405272
Aug 22, 20232 min read
Catalpol: A Potential Treatment for Diabetic Nephropathy
Introduction Diabetic nephropathy (DN) is a common complication of diabetes, characterized by abnormal angiogenesis of glomerular...
946405272
Aug 22, 20234 min read
Postinfectious Cough: A Promising Treatment with Zihua Wenfei Granules
Introduction Postinfectious cough is a bothersome condition that often develops after a respiratory tract infection. It can persist for a...
946405272
Aug 22, 20233 min read
BSN 302: Revolutionizing Diabetes Treatment
Introduction In recent years, the search for innovative solutions to treat diabetes mellitus, particularly type 1 diabetes, has been at...
946405272
Aug 8, 20232 min read
Zijin Tougu Spray: A Breakthrough Treatment for Knee Osteoarthritis
Introduction Knee osteoarthritis (KOA) is a chronic degenerative disease characterized by the destruction of articular cartilage and...
946405272
Aug 7, 20232 min read
Paclitaxel/Ritonavir: A Comprehensive Review on Research and Development
Introduction The research and development of Paclitaxel/Ritonavir, a small molecule drug, has shown promising potential in the treatment...
946405272
Aug 6, 20233 min read
Paclitaxel/Cisplatin: A Comprehensive Review and Research Development
Introduction Paclitaxel and cisplatin are two widely used chemotherapeutic agents in the treatment of various types of cancer....
946405272
Aug 2, 20234 min read
Biogen's Acquisition of Reata Pharmaceuticals
Introduction In a significant development for the medical community, Biogen Inc. (Nasdaq: BIIB) has announced its definitive agreement to...
bottom of page